NSPR InspireMD Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$0,62
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,6052 haftanın en düşüğü
$2,5752 haftanın en yükseği
Piyasa Değeri (MRQ)
$29M
P/E (TTM)
-1.0
Hisse Başına Kâr (TTM)
$-0.61
Gelir (TTM)
$11M
rozetleriniz
52 Haftlık Aralık
$1–$3
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$3
P/E
-1.0
ROE
-202.8%
Net Kâr Marjı
-484.1%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
NSPR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.62
Piyasa Değeri (MRQ)
$29M
P/E (TTM)
-1.0
Hisse Başına Kâr (TTM)
$-0.61
Gelir (TTM)
$11M
ROE (TTM)
-202.8%
52 Haftlık Aralık
$1–$3
NSPR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 27 Nisan 2021 | 1-for-15 | Ters |
| 01 Nisan 2019 | 1-for-50 | Ters |
| 10 Ekim 2016 | 1-for-25 | Ters |
| 01 Ekim 2015 | 1-for-10 | Ters |
| 21 Aralık 2012 | 1-for-4 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$9M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-0.762022-12-31 → 2025-12-31
Serbest Nakit Akışı$-37M2016-12-31 → 2025-12-31
Net kar marjı-484.1%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | NSPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.05Y ort. ≈-2.4 | ≈-2.4 | · | · | |
| F/S (TTM) | 2.75Y ort. ≈7.1 | ≈7.1 | 2.5 | Aşırı değerli | |
| F/D (MRQ) | 0.95Y ort. ≈1.2 | ≈1.2 | 0.9 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -0.75Y ort. ≈-2.2 | ≈-2.2 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -0.75Y ort. ≈-2.3 | ≈-2.3 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.55Y ort. ≈1.2 | ≈1.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | NSPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 18.1%5Y ort. ≈23.7% | ≈23.7% | 33.1% | Zayıf | |
| Faaliyet Kâr Marjı (TTM) | -494.0%5Y ort. ≈-412.1% | ≈-412.1% | -6.0% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | -552.6%5Y ort. ≈-412.1% | ≈-412.1% | -2.2% | Zayıf | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -542.6%5Y ort. ≈-401.3% | ≈-401.3% | -7.7% | Zayıf | |
| Net Kâr Marjı (TTM) | -484.1%5Y ort. ≈-402.1% | ≈-402.1% | -32.5% | Zayıf | |
| ROA (TTM) | -134.6%5Y ort. ≈-63.2% | ≈-63.2% | -30.9% | Zayıf | |
| ROE (TTM) | -202.8%5Y ort. ≈-79.3% | ≈-79.3% | -74.2% | Ortalamanın altında | |
| ROIC | -90.0%5Y ort. ≈-77.7% | ≈-77.7% | -21.7% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | NSPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 3.85Y ort. ≈6.2 | ≈6.2 | 7.4 | Düşük likidite | |
| Cari Oran (MRQ) | 3.35Y ort. ≈4.2 | ≈4.2 | 3.3 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | NSPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 28.1%5Y ort. ≈31.4% | ≈31.4% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 20.2%5Y ort. ≈23.9% | ≈23.9% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 29.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | NSPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.25Y ort. ≈0.2 | ≈0.2 | 0.3 | Zayıf | |
| Inventory Turnover (Stok Devir Hızı) | 2.15Y ort. ≈2.5 | ≈2.5 | 2.1 | Aynı seviyede | |
| Receivables Turnover (Alacak Devir Hızı) | 4.85Y ort. ≈4.6 | ≈4.6 | 7.9 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$70.7K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
10.2%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 14, 2026 | $-0.17 | $-0.20 | 16.7% |
| 31 Mart 2026 | May 12, 2026 | $-0.16 | $-0.18 | 12.9% |
| 31 Aralık 2025 | $-0.14 | $-0.20 | 29.0% | |
| 30 Eylül 2025 | $-0.17 | $-0.20 | 14.5% | |
| 30 Haziran 2025 | $-0.26 | $-0.27 | 2.0% | |
| 31 Mart 2025 | $-0.22 | $-0.20 | -7.8% | |
| 31 Aralık 2024 | $-0.19 | $-0.20 | 4.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $7M | $6M | $5M | $4M | $2M | $4M | $4M | $3M | $2M | $2M | $3M | |
| Cost of Revenue | $6M | $6M | $4M | $4M | $4M | $2M | $3M | $3M | $2M | $2M | $3M | $2M | |
| Gross Profit | $3M | $2M | $2M | $1M | $754.0K | $83.0K | $756.0K | $995.0K | $585.0K | $102.0K | $-296.0K | $784.0K | |
| R&D Expense | $15M | $14M | $8M | $8M | $5M | $2M | $3M | $2M | $1M | $1M | $4M | $9M | |
| SG&A Expense | $21M | $15M | $11M | $8M | $7M | $6M | $5M | $5M | $5M | $5M | $6M | $9M | |
| Operating Expenses | $52M | $35M | $23M | $20M | $15M | $10M | $11M | $9M | $9M | $8M | $14M | $24M | |
| Operating Income | $-50M | $-34M | $-21M | $-19M | $-15M | $-10M | $-10M | $-8M | $-8M | $-8M | $-14M | $-24M | |
| Interest Expense | · | · | · | · | · | · | · | · | $119.0K | $721.0K | $1M | $1M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Other Non-op | $891.0K | $2M | $1M | $250.0K | $-157.0K | $-160.0K | $-200.0K | $-371.0K | · | · | · | $-1M | |
| Pretax Income | $-49M | $-32M | $-20M | $-18M | $-15M | $-11M | $-10M | $-7M | $-8M | $-8M | $-16M | $-25M | |
| Income Tax | $63.0K | $59.0K | $65.0K | $28.0K | $45.0K | $4.0K | $24.0K | · | $27.0K | $1.0K | $4.0K | $12.0K | |
| Net Income | $-49M | $-32M | $-20M | $-18M | $-15M | $-11M | $-10M | $-7M | $-8M | $-8M | $-16M | $-25M | |
| EPS (Basic) | $-0.76 | $-0.76 | $-0.82 | $-2.35 | $-2.03 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.76 | $-0.76 | $-0.82 | $-2.35 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 64,325,810 | 41,928,360 | 24,268,181 | 7,871,814 | 7,346,022 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 64,325,810 | 41,928,360 | 24,268,181 | 7,871,814 | · | · | · | · | · | · | · | · | |
| EBITDA | $-50M | $-34M | $-21M | $-19M | $-15M | $-10M | $-10M | $-7M | $-8M | $-8M | $-14M | $-23M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $19M | $10M | $5M | $12M | $13M | $6M | $9M | $4M | $8M | $3M | $6M | |
| Short-term Investments | $45M | $16M | $29M | · | · | · | · | · | · | · | · | · | |
| Receivables | $2M | $2M | $2M | $1M | $1M | $476.0K | $823.0K | $716.0K | $643.0K | $356.0K | $405.0K | $635.0K | |
| Inventory | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $1M | $533.0K | $500.0K | $753.0K | $2M | |
| Prepaid Expense | $1M | $1M | $578.0K | $655.0K | $522.0K | $334.0K | $87.0K | $81.0K | $62.0K | $65.0K | $75.0K | $150.0K | |
| Current Assets | $61M | $41M | $44M | $21M | $37M | $15M | $8M | $11M | $5M | $9M | $5M | $9M | |
| PP&E (Net) | $4M | $2M | $1M | $917.0K | $632.0K | $448.0K | $547.0K | $421.0K | $476.0K | $379.0K | $472.0K | $622.0K | |
| PP&E (Gross) | $6M | $5M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Accum. Depreciation | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $957.0K | $875.0K | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | $752.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Total Assets | $69M | $47M | $48M | $25M | $40M | $18M | $10M | $12M | $6M | $9M | $6M | $11M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Accrued Liabilities | $2M | $1M | $1M | $554.0K | $632.0K | $886.0K | $604.0K | $903.0K | $976.0K | $425.0K | $552.0K | $993.0K | |
| Current Liabilities | $11M | $8M | $6M | $5M | $4M | $4M | $3M | $3M | $2M | $5M | $7M | $8M | |
| Capital Leases | $2M | $2M | $1M | $1M | $781.0K | $999.0K | $653.0K | · | · | · | · | · | |
| Total Liabilities | $14M | $11M | $8M | $7M | $6M | $6M | $4M | $4M | $3M | $5M | $9M | $14M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $5M | $9M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $3M | $5M | · | |
| Common Stock | $4.0K | $3.0K | $2.0K | $1.0K | $1.0K | · | · | · | · | · | · | $4.0K | |
| Paid-in Capital | $357M | $290M | $261M | $219M | $217M | $180M | $163M | $156M | $143M | $136M | $120M | · | |
| Retained Earnings | $-302M | $-254M | $-222M | $-202M | $-183M | $-168M | $-158M | $-148M | $-140M | $-132M | $-123M | $-107M | |
| Stockholders' Equity | $55M | $36M | $40M | $17M | $34M | $12M | $5M | $9M | $3M | $4M | $-3M | $-3M | |
| Liabilities + Equity | $69M | $47M | $48M | $25M | $40M | $18M | $10M | $12M | $6M | $9M | $6M | $11M | |
| Shares Outstanding | 43,532,281 | 26,611,033 | 21,841,215 | 8,330,918 | 8,296,256 | 3,284,322 | 3,916,134 | 38,400,000 | 1,483,556 | 42,653 | 314,065 | 4,136,852 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $476M | $280M | $232M | $188M | $161.0K | $151.0K | $158.0K | $152.0K | $153.0K | $142.0K | $152.0K | $263.0K | |
| Stock-based Comp | $12M | $10M | $4M | $2M | $2M | $606.0K | $325.0K | $70.0K | $672.0K | $978.0K | $3M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $148.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $406.0K | · | |
| Other Non-cash | · | · | · | · | · | $706.0K | $-253.0K | $-575.0K | $-518.0K | $-154.0K | $641.0K | $1M | |
| Operating Cash Flow | $-35M | $-22M | $-16M | $-16M | $-13M | $-9M | $-10M | $-8M | $-8M | $-7M | $-12M | $-19M | |
| CapEx | $2M | $1M | $381.0K | $473.0K | $344.0K | $88.0K | $284.0K | $67.0K | $258.0K | $49.0K | $16.0K | $133.0K | |
| Investing Cash Flow | $-31M | $13M | $-16M | $8M | $-22M | $-187.0K | $-387.0K | $-44.0K | $-318.0K | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $-2M | $-3M | $-4M | $-1M | |
| Stock Issued | $1M | $1M | · | · | · | · | $6M | $16M | $7M | $14M | $12M | $10M | |
| Net Stock Activity | $1M | $1M | · | · | · | · | $6M | $16M | $7M | $14M | $12M | $10M | |
| Financing Cash Flow | $56M | $18M | $38M | $-140.0K | $35M | $16M | $6M | $13M | $5M | · | · | · | |
| Net Change in Cash | $-10M | $9M | $5M | $-7M | $-641.0K | $7M | $-4M | $6M | $-4M | $4M | $-3M | $-11M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $6.0K | $13.0K | · | |
| Free Cash Flow | $-37M | $-23M | $-17M | $-16M | $-14M | $-9M | $-10M | $-8M | $-8M | $-8M | $-12M | $-19M | |
| Levered FCF | · | · | · | · | · | · | · | · | $-9M | $-8M | $-13M | $-21M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.5% | 21.5% | 29.1% | 21.6% | 16.8% | 3.3% | 20.3% | 27.6% | 21.2% | 5.4% | -12.8% | 27.8% | |
| Operating Margin | -552.6% | -478.0% | -340.7% | -361.9% | -327.4% | -417.7% | -263.8% | -211.4% | -298.1% | -403.8% | -627.1% | -840.9% | |
| Net Margin | -543.3% | -456.6% | -321.0% | -357.6% | -331.9% | -424.3% | -269.8% | -201.1% | -305.6% | -446.7% | -674.7% | -890.5% | |
| Pretax Margin | -542.6% | -455.8% | -319.9% | -357.1% | -330.9% | -424.1% | -269.2% | -201.1% | -304.6% | -446.7% | -674.5% | -890.1% | |
| EBITDA Margin | -552.6% | -478.0% | -340.7% | -361.9% | -327.4% | -411.6% | -259.6% | -207.5% | -292.6% | -396.3% | -616.6% | -831.6% | |
| ROA | -84.0% | -67.8% | -55.1% | -57.5% | -51.9% | -76.2% | -90.6% | -78.7% | -108.8% | -112.0% | -200.6% | -141.7% | |
| ROE | -129.3% | -82.7% | -48.1% | -94.2% | -42.3% | -90.0% | -151.2% | -73.5% | -249.2% | -1539.8% | 885.5% | -857.5% | |
| ROIC | -90.0% | -93.0% | -53.7% | -107.7% | -44.0% | -85.4% | -182.8% | · | -302.8% | -113.7% | -607.0% | 850.7% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 5.3 | 7.3 | 4.2 | 8.5 | 4.1 | 2.5 | 3.9 | 2.1 | 1.8 | 0.7 | 1.1 | |
| Quick Ratio | 5.3 | 4.7 | 6.8 | 1.1 | 3.0 | 3.5 | 2.0 | 3.5 | 1.8 | 1.6 | 0.5 | 0.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.7 | -1.8 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | -0.4 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -69.2 | -10.6 | -14.0 | -16.8 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.2 | |
| Inventory Turnover | 2.1 | 2.4 | 2.4 | 2.9 | 2.9 | 1.8 | 2.5 | · | · | · | 2.8 | 1.2 | |
| Receivables Turnover | 4.8 | 4.2 | 4.4 | 4.6 | 5.3 | 3.8 | 4.8 | 5.3 | 5.5 | 5.0 | 4.3 | 2.3 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.27 | $1.36 | $1.81 | $2.09 | $4.04 | $0.25 | $1.37 | $0.23 | $1.84 | $2.74 | $-0.38 | $-0.07 | |
| Revenue / Share | $0.14 | $0.17 | $0.26 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.55 | $-0.52 | $-0.67 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.21 | $0.71 | $0.44 | $0.56 | $1.45 | $0.26 | $1.41 | $0.24 | $2.50 | $5.09 | $0.42 | $0.15 | |
| EPS (TTM) | $-0.76 | $-0.76 | $-0.82 | $-2.35 | · | · | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 28.1% | 13.0% | 20.0% | 15.0% | 80.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 20.2% | 16.0% | 35.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 29.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $7M | $6M | $5M | $4M | $2M | $4M | $4M | $3M | $2M | $2M | $3M | |
| Net Income TTM | $-49M | $-32M | $-20M | $-18M | $-15M | $-11M | $-10M | $-7M | $-8M | $-8M | $-16M | $-25M | |
| Market Cap | $77M | $70M | $61M | $7M | $25M | $251M | $63M | $4.61B | $5.06B | $96.82B | $4.43T | $211.76T | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $96.81B | $4.43T | · | |
| P/E | -2.3 | -3.5 | -3.4 | -0.4 | · | · | · | · | · | · | · | · | |
| P/S | 8.6 | 10.0 | 9.9 | 1.4 | 5.6 | 101.1 | 17.0 | 1279.9 | 1833.9 | 51118.1 | 1919018.5 | 75144428.9 | |
| P/B | 1.4 | 1.9 | 1.6 | 0.4 | 0.7 | 20.7 | 11.8 | 526.0 | 1856.8 | 23935.2 | -1504729.4 | -75980265.7 | |
| P / Tangible Book | 1.4 | 1.9 | 1.6 | 0.4 | 0.7 | 20.7 | · | · | · | · | · | · | |
| P / Cash Flow | -2.2 | -3.2 | -3.7 | -0.5 | -1.9 | -27.7 | -6.5 | -606.0 | -622.7 | -12917.6 | -382281.2 | -10936731.8 | |
| P / FCF | -2.1 | -3.0 | -3.7 | -0.4 | -1.8 | -27.4 | -6.3 | -600.7 | -603.6 | -12833.7 | -381754.5 | -10862118.5 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | -12898.1 | -311214.2 | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -12833.1 | -381754.6 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 51115.6 | 1919019.4 | · | |
| Earnings Yield | -42.7% | -28.9% | -29.2% | -273.3% | · | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Cost of Revenue | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $866.0K | $828.0K | $1M | |
| Gross Profit | $-774.0K | $687.0K | $1M | $864.0K | $313.0K | $292.0K | $469.0K | $414.0K | $331.0K | $292.0K | $505.0K | $438.0K | $491.0K | $373.0K | $198.0K | $366.0K | |
| R&D Expense | $4M | $5M | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $4M | $5M | $5M | $6M | $5M | $5M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Operating Expenses | $14M | $15M | $13M | $14M | $13M | $12M | $10M | $9M | $9M | $8M | $6M | $6M | $6M | $5M | $5M | $5M | |
| Operating Income | $-14M | $-14M | $-12M | $-13M | $-13M | $-11M | $-9M | $-8M | $-8M | $-7M | $-6M | $-6M | $-5M | $-4M | $-5M | $-5M | |
| Other Non-op | $121.0K | $289.0K | $386.0K | $343.0K | $-132.0K | $294.0K | $252.0K | $572.0K | $351.0K | $382.0K | $468.0K | $461.0K | $238.0K | $125.0K | $119.0K | $81.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | $-5M | |
| Net Income | $-14M | $-14M | $-12M | $-13M | $-13M | $-11M | $-9M | $-8M | $-8M | $-7M | $-5M | $-5M | $-5M | $-4M | $-5M | $-5M | |
| EPS (Basic) | $-0.17 | $-0.16 | $-0.11 | $-0.17 | $-0.26 | $0.22 | $-0.17 | $-0.16 | $-0.22 | $-0.21 | $0.10 | $-0.15 | $-0.24 | $-0.53 | $-0.61 | $-0.58 | |
| EPS (Diluted) | $-0.17 | $-0.16 | $-0.11 | $-0.17 | $-0.26 | $0.22 | $-0.17 | $-0.16 | $-0.22 | $-0.21 | $0.10 | $-0.15 | $-0.24 | $-0.53 | $-0.60 | $-0.58 | |
| Shares (Basic) | 84,659,943 | 83,801,839 | · | 73,466,501 | 51,003,900 | 49,993,509 | · | 48,369,412 | 35,877,926 | 34,242,976 | · | 33,984,953 | 21,074,187 | 8,093,340 | · | 7,838,506 | |
| Shares (Diluted) | 84,659,943 | 83,801,839 | · | 73,466,501 | 51,003,900 | 49,993,509 | · | 48,369,412 | 35,877,926 | 34,242,976 | · | 33,984,953 | 21,074,187 | 8,093,340 | · | 7,838,506 | |
| EBITDA | $-14M | $-14M | · | $-13M | $-13M | $-11M | · | $-8M | $-8M | $-7M | · | $-6M | $-5M | $-4M | · | $-5M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $11M | $9M | $63M | $12M | $12M | $19M | $16M | $28M | $9M | $10M | $14M | $12M | $4M | $5M | $4M | |
| Short-term Investments | $15M | $30M | $45M | · | $8M | $14M | $16M | $25M | $19M | $25M | $29M | $29M | $29M | · | · | · | |
| Receivables | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Inventory | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Prepaid Expense | $1M | $1M | $1M | $945.0K | $947.0K | $893.0K | $1M | $1M | $717.0K | $531.0K | $578.0K | $476.0K | $56.0K | $394.0K | $655.0K | $860.0K | |
| Current Assets | $37M | $49M | $61M | $70M | $25M | $32M | $41M | $46M | $52M | $39M | $44M | $47M | $51M | $17M | $21M | $25M | |
| PP&E (Net) | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $907.0K | $873.0K | $887.0K | $917.0K | $876.0K | |
| PP&E (Gross) | · | · | $6M | · | · | · | $5M | · | · | · | $3M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Total Assets | $45M | $56M | $69M | $78M | $33M | $39M | $47M | $50M | $56M | $42M | $48M | $50M | $54M | $20M | $25M | $28M | |
| Accrued Liabilities | $1M | $1M | $2M | $735.0K | $1M | $821.0K | $1M | $1M | $1M | $1M | $1M | $926.0K | $742.0K | $933.0K | $554.0K | $1M | |
| Current Liabilities | $10M | $9M | $11M | $11M | $9M | $7M | $8M | $7M | $7M | $5M | $6M | $5M | $5M | $4M | $5M | $4M | |
| Capital Leases | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $682.0K | $786.0K | $914.0K | $1M | $1M | $970.0K | $1M | $1M | $1M | |
| Total Liabilities | $13M | $13M | $14M | $14M | $13M | $10M | $11M | $9M | $9M | $7M | $8M | $7M | $7M | $6M | $7M | $6M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $362M | $360M | $357M | $355M | $298M | $293M | $290M | $286M | $283M | $264M | $261M | $259M | $258M | $219M | $219M | $219M | |
| Retained Earnings | $-330M | $-316M | $-302M | $-291M | $-278M | $-265M | $-254M | $-244M | $-236M | $-229M | $-222M | $-216M | $-211M | $-206M | $-202M | $-197M | |
| Stockholders' Equity | $32M | $44M | $55M | $64M | $20M | $28M | $36M | $41M | $47M | $35M | $40M | $43M | $47M | $13M | $17M | $22M | |
| Liabilities + Equity | $45M | $56M | $69M | $78M | $33M | $39M | $47M | $50M | $56M | $42M | $48M | $50M | $54M | $20M | $25M | $28M | |
| Shares Outstanding | 46,921,061 | 46,838,963 | 43,532,281 | 41,919,141 | 32,552,888 | 29,752,661 | 26,611,033 | 25,719,632 | 25,196,479 | 23,412,385 | 21,841,215 | 21,400,163 | 21,192,204 | 8,326,648 | 8,330,918 | 8,335,606 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $3M | $4M | $3M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $930.0K | $289.0K | $368.0K | $657.0K | |
| Operating Cash Flow | $-11M | $-12M | $-9M | $-9M | $-8M | $-9M | $-7M | $-6M | $-4M | $-5M | $-4M | $-4M | $-3M | $-5M | $-3M | $-5M | |
| CapEx | $330.0K | $194.0K | $398.0K | $329.0K | $576.0K | $359.0K | $311.0K | $421.0K | $475.0K | $195.0K | $215.0K | $96.0K | $45.0K | $25.0K | $95.0K | $226.0K | |
| Investing Cash Flow | $15M | $15M | $-45M | $8M | $5M | $2M | $8M | $-6M | $6M | $5M | $-36.0K | $6M | $-27M | $4M | $4M | $3M | |
| Stock Issued | · | · | $-38M | $38M | $190.0K | $506.0K | $965.0K | $-965.0K | $1M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $506.0K | · | · | $1M | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $0 | $53M | $2M | $506.0K | $2M | $-965.0K | · | · | $0 | $0 | · | · | $0 | $-103.0K | |
| Net Change in Cash | $4M | $2M | $-54M | $52M | $-874.0K | $-7M | $3M | $-13M | $19M | $-251.0K | $-4M | $2M | $7M | $-404.0K | $698.0K | $-2M | |
| Free Cash Flow | · | $-13M | · | · | · | $-9M | · | · | · | $-5M | · | · | · | $-5M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -43.7% | 20.2% | · | 34.2% | 17.6% | 19.1% | · | 22.9% | 19.0% | 19.3% | · | 28.1% | 29.8% | 30.1% | · | 25.6% | |
| Operating Margin | -815.6% | -411.4% | · | -517.3% | -732.2% | -749.5% | · | -467.5% | -475.0% | -490.7% | · | -362.4% | -322.3% | -353.6% | · | -322.1% | |
| Net Margin | -808.8% | -402.9% | · | -503.7% | -739.6% | -730.3% | · | -435.9% | -454.8% | -465.4% | · | -332.8% | -307.9% | -343.5% | · | -316.5% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -316.5% | |
| EBITDA Margin | -815.6% | -411.4% | · | -517.3% | -732.2% | -749.5% | · | -467.5% | -475.0% | -490.7% | · | -362.4% | -322.3% | -353.6% | · | -322.1% | |
| ROA | -36.7% | -28.8% | · | -19.7% | -29.5% | -27.7% | · | -15.7% | -14.5% | -22.7% | · | -13.3% | -11.8% | -15.4% | · | -12.8% | |
| ROE | -55.4% | -38.0% | · | -24.1% | -39.2% | -35.2% | · | -18.6% | -16.9% | -29.0% | · | -15.9% | -14.0% | -19.7% | · | -15.4% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 5.1 | · | 6.5 | 2.8 | 4.4 | · | 6.4 | 7.4 | 7.9 | · | 10.0 | 10.5 | 3.8 | · | 6.2 | |
| Quick Ratio | 3.3 | 4.7 | · | 6.0 | 2.3 | 3.8 | · | 5.8 | 7.0 | 7.2 | · | 9.4 | 8.7 | 1.3 | · | 1.3 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.9 | 0.9 | · | 0.5 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.6 | · | 0.7 | 0.7 | 0.6 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.7 | · | 1.4 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.2 | · | 1.4 | 1.2 | 1.0 | · | 1.3 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.67 | $0.93 | · | $1.53 | $0.62 | $0.95 | · | $1.61 | $1.86 | $1.50 | · | $2.02 | $2.21 | $1.61 | · | $2.62 | |
| Revenue / Share | $0.02 | $0.04 | · | $0.03 | $0.03 | $0.03 | · | $0.04 | $0.05 | $0.04 | · | $0.05 | $0.08 | · | · | · | |
| Cash Flow / Share | · | $-0.15 | · | · | · | $-0.18 | · | · | · | $-0.15 | · | · | · | · | · | · | |
| Cash / Share | $0.32 | $0.24 | · | $1.51 | $0.35 | $0.42 | · | $0.61 | $1.13 | $0.40 | · | $0.65 | $0.54 | $0.51 | · | $0.47 | |
| EPS (TTM) | $-0.61 | $-0.70 | · | $-0.38 | $-0.37 | $-0.33 | · | $-0.49 | $-0.48 | $-0.50 | · | $-1.52 | $-1.95 | $-2.30 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | $11M | · | $8M | $7M | $7M | · | $7M | $7M | $6M | · | $5M | $5M | $5M | · | $6M | |
| Net Income TTM | $-52M | $-51M | · | $-46M | $-41M | $-36M | · | $-28M | $-26M | $-23M | · | $-19M | $-19M | $-18M | · | $-18M | |
| Market Cap | $33M | $76M | · | $101M | $74M | $80M | · | $69M | $63M | $55M | · | $70M | $53M | $9M | · | $12M | |
| P/E | -1.1 | -2.3 | · | -6.3 | -6.1 | -8.2 | · | -5.5 | -5.2 | -4.7 | · | -2.2 | -1.3 | -0.5 | · | · | |
| P/S | 3.0 | 7.0 | · | 13.0 | 10.5 | 11.4 | · | 10.1 | 9.6 | 8.6 | · | 12.8 | 10.0 | 1.8 | · | 2.2 | |
| P/B | 1.0 | 1.8 | · | 1.6 | 3.7 | 2.8 | · | 1.7 | 1.3 | 1.6 | · | 1.6 | 1.1 | 0.7 | · | 0.6 | |
| P / Tangible Book | 1.0 | 1.8 | · | 1.6 | 3.7 | 2.8 | · | 1.7 | 1.3 | 1.6 | · | 1.6 | 1.1 | 0.7 | · | 0.6 | |
| P / Cash Flow | · | -6.2 | · | · | · | -9.1 | · | · | · | -11.0 | · | · | · | -1.9 | · | · | |
| Earnings Yield | -87.1% | -42.9% | · | -15.8% | -16.3% | -12.3% | · | -18.3% | -19.2% | -21.1% | · | -46.5% | -77.7% | -203.5% | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $9M | $7M | $6M | $5M | $4M |
| Brüt Kâr Marjı % | 29.5% | 21.5% | 29.1% | 21.6% | 16.8% |
| Faaliyet Kâr Marjı % | -552.6% | -478.0% | -340.7% | -361.9% | -327.4% |
| Net Gelir | $-49M | $-32M | $-20M | $-18M | $-15M |
| Seyreltilmiş Hisse Başı Kâr | $-0.76 | $-0.76 | $-0.82 | $-2.35 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 5.7 | 5.3 | 7.3 | 4.2 | 8.5 |
| Cari Oran | 5.3 | 4.7 | 6.8 | 1.1 | 3.0 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-37M | $-23M | $-17M | $-16M | $-14M |
Kurumsal Sahipler (13F) 38 dosya · $14.8M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
38
Tutulan Değer
$14.8M
Yeni pozisyonlar
8
Çıkan pozisyonlar
3
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 8 (+5 önceki Ç'ye göre) | 3 (-9 önceki Ç'ye göre) | 10 (+6 önceki Ç'ye göre) | 5 (-5 önceki Ç'ye göre) | -1.2M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $2.734.411 | 3.905.743 | 18,52% | Hisse senetleri |
| Aberdeen Group plc | $2.589.225 | 3.698.364 | 17,53% | Hisse senetleri |
| Nantahala Capital Management, LLC | $2.363.876 | 3.376.484 | 16,01% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $2.193.697 | 3.133.405 | 14,85% | Hisse senetleri |
| Parkman Healthcare Partners LLC | $1.691.804 | 2.416.518 | 11,46% | Hisse senetleri |
| MARSHALL WACE, LLP | $1.302.284 | 1.860.405 | 8,82% | Hisse senetleri |
| Soleus Capital Management, L.P. | $732.100 | 1.045.708 | 4,96% | Hisse senetleri |
| PURA VIDA INVESTMENTS, LLC | $315.407 | 450.517 | 2,14% | Hisse senetleri |
| Affiance Financial, LLC | $175.284 | 250.370 | 1,19% | Hisse senetleri |
| Velan Capital Investment Management LP | $103.711 | 148.138 | 0,70% | Hisse senetleri |
| BlackRock, Inc. | $86.108 | 122.993 | 0,58% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $78.994 | 112.832 | 0,53% | Hisse senetleri |
| Creative Planning | $76.286 | 108.964 | 0,52% | Hisse senetleri |
| Schonfeld Strategic Advisors LLC | $69.502 | 99.275 | 0,47% | Hisse senetleri |
| XTX Topco Ltd | $34.325 | 49.029 | 0,23% | Hisse senetleri |
| Centiva Capital, LP | $30.891 | 44.123 | 0,21% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $26.378 | 37.677 | 0,18% | Hisse senetleri |
| Mesirow Financial Investment Management, Inc. | $21.003 | 30.000 | 0,14% | Hisse senetleri |
| COURIER CAPITAL LLC | $21.003 | 30.000 | 0,14% | Hisse senetleri |
| MORGAN STANLEY | $19.863 | 28.371 | 0,13% | Hisse senetleri |
| VESTIA PERSONAL WEALTH ADVISORS | $17.100 | 24.425 | 0,12% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.418 | 20.594 | 0,10% | Hisse senetleri |
| LPL Financial LLC | $13.037 | 18.621 | 0,09% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $11.165 | 15.952 | 0,08% | Hisse senetleri |
| Avestar Capital, LLC | $10.502 | 15.000 | 0,07% | Hisse senetleri |
| CITADEL ADVISORS LLC | $9.521 | 13.600 | 0,06% | Alım opsiyonu |
| Pallas Capital Advisors LLC | $7.701 | 11.000 | 0,05% | Hisse senetleri |
| McKinley Carter Wealth Services, Inc. | $7.001 | 10.000 | 0,05% | Hisse senetleri |
| AdvisorNet Financial, Inc | $6.149 | 8.783 | 0,04% | Hisse senetleri |
| UBS Group AG | $3.720 | 5.314 | 0,03% | Hisse senetleri |
| Farther Finance Advisors, LLC | $700 | 1.000 | 0,00% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $521 | 745 | 0,00% | Hisse senetleri |
| INGALLS & SNYDER LLC | $258 | 368.800 | 0,00% | Hisse senetleri |
| HRT FINANCIAL LP | $41 | 59.754 | 0,00% | Hisse senetleri |
| Cambridge Investment Research Advisors, Inc. | $14 | 20.166 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0,00% | Hisse senetleri |
| CITIGROUP INC | $1 | 1 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 247 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 7 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Marvin Slosman | 24 Nisan 2026 | 5,18% | İlk başvuru | · | SEC |
| Michael A. Lawless | 29 Ekim 2025 | 8,60% | İlk başvuru | · | SEC |
| Craig Shore ×2 başvurular | 29 Ekim 2025 | 3,50% | Değişiklik | · | SEC |
| Sol J. Barer ×3 başvurular | 20 Nisan 2016 | · | İlk başvuru | · | SEC |
| OFIR PAZ, SARA PAZ ×2 başvurular | 28 Ocak 2014 | · | İlk başvuru | Pasif yatırım | SEC |
| Asher Holzer ×2 başvurular | 16 Ocak 2014 | · | İlk başvuru | · | SEC |
| OrbiMed Israel BioFund GP Limited Partnership, OrbiMed Israel GP Ltd., OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC, Samuel D. Isaly | 22 Nisan 2013 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 27 içeriden öğrenenler · 13 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Marvin Slosman | CEO and President | 12 Mayıs 2026 P | 3.556.658 | 1 | 0 | $25.200 |
| James J Barry | President and CEO | 16 Aralık 2019 A | 2.166.382 | 0 | 0 | $0 |
| Alan Milinazzo | President and CEO | 31 Ocak 2016 F | 158.718 | 0 | 0 | $0 |
| Ofir Paz | CHIEF EXECUTIVE OFFICER | 08 Nisan 2011 A | · | 0 | 0 | $0 |
| Michael A. Lawless | Chief Financial Officer | 14 Ocak 2026 A | 691.695 | 0 | 0 | $0 |
| Craig Shore | CFO and CAO | 07 Ocak 2025 A | 1.112.460 | 0 | 0 | $0 |
| Andrea Tommasoli | Chief Operating Officer | 14 Ocak 2026 A | 954.389 | 0 | 0 | $0 |
| Shane Thomas Gleason | Chief Commercial Officer | 19 Mayıs 2026 S | 1.053.882 | 0 | 24 | $-288.783 |
| Patrick Verta | EVP Clinical/Medical Affairs | 07 Ocak 2025 A | 311.532 | 0 | 0 | $0 |
| Agustin V Gago | EVP, Chief Commercial Officer | 24 Ekim 2016 A | · | 0 | 0 | $0 |
| Eli Bar | CTO InspireMD Ltd. | 26 Ocak 2015 A | 342.919 | 0 | 0 | $0 |
| Eric L. Olson | VP of Global Sales Operations | 07 Kasım 2014 P | 147.163 | 0 | 0 | $0 |
| Robert Ratini | VP Sales Mkting InspireMD Ltd. | 01 Haziran 2012 A | · | 0 | 0 | $0 |
| Paul Stuka | Yönetim kurulu üyesi | 18 Eylül 2026 J | 667.871 | 14 | 0 | $284.057 |
| Michael Berman | Yönetim kurulu üyesi | 18 Eylül 2026 J | 352.586 | 0 | 0 | $0 |
| Gary S Roubin | Yönetim kurulu üyesi | 18 Eylül 2026 J | 834.478 | 1 | 0 | $106.200 |
| Scott R. Ward | Yönetim kurulu üyesi | 07 Mayıs 2026 P | 237.096 | 2 | 0 | $102.637 |
| Danny L. Dearen | Yönetim kurulu üyesi | 14 Ocak 2026 A | 102.047 | 0 | 0 | $0 |
| Raymond W Cohen | Yönetim kurulu üyesi | 14 Ocak 2026 A | 92.417 | 0 | 0 | $0 |
| Kathryn Arnold | Yönetim kurulu üyesi | 30 Aralık 2025 A | 303.087 | 0 | 0 | $0 |
| Thomas J Kester | Yönetim kurulu üyesi | 15 Eylül 2025 A | 458.573 | 0 | 0 | $0 |
| Campbell Rogers | Yönetim kurulu üyesi | 13 Ekim 2021 A | 27.960 | 0 | 0 | $0 |
| Sol J Barer | Yönetim kurulu üyesi | 07 Aralık 2016 A | 1.141.690 | 0 | 0 | $0 |
| Isaac Blech | Yönetim kurulu üyesi | 07 Aralık 2016 A | · | 0 | 0 | $0 |
| James J Loughlin | Yönetim kurulu üyesi | 21 Mart 2016 P | 51.501 | 0 | 0 | $0 |
| Asher Holzer | Yönetim kurulu üyesi | 26 Kasım 2013 S | 1.925.110 | 0 | 0 | $0 |
| Eyal Weinstein | Yönetim kurulu üyesi | 09 Mayıs 2013 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 114.077 SH | 10 Eylül 2026 | Günlük |
NSPR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$3.00
+381,9%
2 22,2%
Güçlü Al
6 66,7%
Al
1 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-09-27Ortalama hedef $3.33 +435,5%
← Tüm hedeflerin altında
Mevcut fiyat $0.62
Düşük$3.00
Ortalama$3.33
Yüksek$4.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| NSPR | $77M | -2.3 | 28.1% | -543.3% | -129.3% | 29.5% |
| RXST | $430M | -11.0 | -3.9% | -29.0% | -14.0% | 76.6% |
| SKYA | · | · | · | · | · | · |
| TELA | $53M | -1.4 | 15.8% | -48.4% | -501.1% | 67.7% |
| RMTI | $33M | -5.5 | -31.8% | -7.7% | -15.8% | 16.9% |
| ADVB | $15M | -4.4 | · | · | -159.1% | · |
| LUCY | · | · | · | · | · | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026